Business View Magazine | March 2019

259 driver in the market. I believe we will see a substantially increased legal use of medical cannabis. They’ll move it beyond epilepsy and add other neurological conditions, but really to try to force you to use these three entities. And I don’t think those three will be able to sup- port the demand.” Williams: “I want to also emphasize the dif- ference in our Pebble product versus others we’ve seen. There are a lot of snake oil people out there who will put 5mg. of CBD in a prod- uct and sell it for $20 and cast it as a cure-all, when it does nothing for you. It’s like drink- ing water. In our 1 oz. bottle, we have 1,500 mg. of CBD, which is on the very high end of what everybody in the market is doing. Having people understand what makes the Pebble line different is going to be a challenge. It’s what differentiates us from other companies that are going with really low doses and playing the price point game.” BVM: How are you getting the message out about Pebble? Moran: “We’re moving into the second phase of a multi-tiered marketing plan. The pre-step was to create a worthy product that might not stand out immediately because of the white noise, but the more you shine the light on it, the better it’s going to look against the other players. The first two products we chose, we went against the market, and said, ‘We have a highly concentrated product, and we want to talk to epileptics, autistic families, PTSD survi- vors because we have something that will help change your family’s life.’ “We work closely with national and state-level advocacy groups – that’s how we developed our autism trial. It is designed for seriously au- tistic children ages 5 to 12, and those families have been reporting back to us on a weekly basis. We have young children who have been non-verbal their entire life, unable to sit in a room with other children, and since they’ve been taking 100 mg. a day of our Pebble prod- uct over a period of weeks, for the first time, ever, they are verbal, communicating with their families, socializing. It is all documented. There are no control placebos.